| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -142,012 | 100% | $1.73 | -$245,484 |
| Net | -1 | -142,012 | -100% | -$245,484 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Shalom Auerbach | Former 10% Owner | $5,356,349 | -$245,484 | -4.4% | 09 May 2025 |
| Paul A. Romness | President and CEO, Director | $3,808,420 | 22 Jan 2026 | ||
| Colin Goddard | Director | $1,516,581 | 31 Dec 2024 | ||
| John Ciccio | Director | $701,985 | 22 Jan 2026 | ||
| Theodore F. Search | Director | $701,985 | 22 Jan 2026 | ||
| Robert Petit | Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated. | $308,000 | 22 Jan 2026 | ||
| Christopher P. Acevedo | Chief Financial Officer | $168,437 | 22 Jan 2026 | ||
| Avril McKean-Dieser | Director | $7,700 | 22 Jan 2026 | ||
| Olivier Roger Jarry | Director | 22 Jan 2026 | |||
| Karim Galzahr | Director | 22 Jan 2026 | |||
| Joacim Borg | Director | 31 Jul 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|